J. Biol. Chem., Vol. 261, Issue 11, 5010-5017, Apr, 1986
Partial purification and characterization of phorbol ester-regulated translational inhibitor(s) in human HL-60 leukemic cells
S Konno, TJ Borelli and JM Wu
Addition of nanomolar concentration of the phorbol ester 12-O-
tetradecanoyl phorbol 13-acetate (TPA) to the human promyelocytic HL-60
leukemia cells is associated with a cessation of cellular proliferation and
a subsequent differentiation into macrophage-like cells. Because the growth
rate of mammalian cells is tightly coupled to the functions of the protein
synthetic machinery, we have examined whether TPA induces a change in HL-60
translational functions. Addition of control HL-60 cell extracts to rabbit
reticulocyte lysates results in a pronounced inhibition of protein
synthesis, while TPA-treated HL-60 cell extracts are significantly less
inhibitory. The reduction in TPA- induced translational inhibitory activity
can be observed after a 3-6-h treatment and reaches a maximum after 24 h.
Fractionation of control cell extracts on DEAE-cellulose columns reveals
two inhibitory activities, eluting at 100 and 350 mM KCl, respectively. The
DEAE-100 inhibitor(s) is further resolved into two activities by
heparin-agarose column chromatography (HEP-100 and HEP-250). TPA treatment
of HL-60 cells for 48 h completely eliminates the HEP-250 inhibitory
activity and reduces the HEP-100 and the DEAE-350 inhibitory activities by
50 and 25%. Inhibition of protein synthesis in rabbit reticulocyte lysates
by DEAE-100 inhibitory activities can be partially reversed by the addition
of globin mRNA while translational inhibition by DEAE-350 inhibitor(s) can
be reversed by addition of eukaryotic initiation factor (eIF) 2 or fructose
6-phosphate. The DEAE-100 inhibitor(s) causes extensive degradation of
radioactive polynucleotides while the DEAE-350 inhibitor(s) is capable of
phosphorylating both the alpha- and the beta-subunits of the highly
purified rabbit reticulocyte initiation factor eIF-2. These data show that
the DEAE-100 inhibitor(s) contains a nuclease while the DEAE-350
inhibitor(s) is associated with eIF-2 alpha and eIF-2 beta protein kinases.